Tiansheng Pharmaceutical Group Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -20.15% vs 41.77% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 3.92% vs -14.61% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "132.00",
          "val2": "165.30",
          "chgp": "-20.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.40",
          "val2": "10.80",
          "chgp": "-214.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "-0.20",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.80",
          "val2": "-10.20",
          "chgp": "3.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-93.70%",
          "val2": "-148.50%",
          "chgp": "5.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.84% vs -1.74% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 36.44% vs 5.98% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "510.10",
          "val2": "565.80",
          "chgp": "-9.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.50",
          "val2": "17.70",
          "chgp": "117.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.30",
          "val2": "14.80",
          "chgp": "-23.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-21.90",
          "chgp": "100.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-56.00",
          "val2": "-88.10",
          "chgp": "36.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-172.90%",
          "val2": "-168.30%",
          "chgp": "-0.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

132.00

165.30

-20.15%

Operating Profit (PBDIT) excl Other Income

-12.40

10.80

-214.81%

Interest

3.60

0.00

Exceptional Items

0.40

-0.20

300.00%

Consolidate Net Profit

-9.80

-10.20

3.92%

Operating Profit Margin (Excl OI)

-93.70%

-148.50%

5.48%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -20.15% vs 41.77% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 3.92% vs -14.61% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

510.10

565.80

-9.84%

Operating Profit (PBDIT) excl Other Income

38.50

17.70

117.51%

Interest

11.30

14.80

-23.65%

Exceptional Items

0.20

-21.90

100.91%

Consolidate Net Profit

-56.00

-88.10

36.44%

Operating Profit Margin (Excl OI)

-172.90%

-168.30%

-0.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.84% vs -1.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 36.44% vs 5.98% in Dec 2024

All Annual Results